Re: The problem...as I see it

...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10553 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: The problem...as I see it

in response to

Re: The problem...as I see it

barsax

posted on Oct 16, 2020 01:43PM

I believe what we are talking about is Invokana, correct? (patients with type 2DM and CVD). Note FDA approval (underscored) below.

https://www.tctmd.com/news/diabetes-drug-canagliflozin-gets-mace-reduction-indication

Janssen. US FDA approves Invokana (canagliflozin) to reduce the risk of heart attack, stroke, or cardiovascular death in adults with type 2 diabetes and established cardiovascular disease. Published on: October 30, 2018. Accessed on: November 1, 2018.